Why the study?
Do intravenous NMDA receptor antagonists reduce postoperative pain and analgesic consumption in adults receiving remifentanil-based anesthesia?
Do intravenous NMDA receptor antagonists reduce postoperative pain and analgesic consumption in adults receiving remifentanil-based anesthesia?
Intravenous NMDA receptor antagonists effectively prevent remifentanil-induced postoperative hyperalgesia and tolerance, reducing pain intensity and analgesic consumption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Samanci et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: